###begin article-title 0
A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75
###end article-title 0
###begin p 1
Current address: School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Australia
###end p 1
###begin p 2
Conceived and designed the experiments: SH AE PC. Performed the experiments: SH MCS SSG EV AE PC. Analyzed the data: SH MCS SSG AE PC. Wrote the paper: SH AE PC.
###end p 2
###begin p 3
###xml 266 276 266 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 998 1006 998 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 478 483 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1054 1059 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1148 1153 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Lens epithelium derived growth factor (LEDGF), also known as PC4 and SFRS1 interacting protein 1 (PSIP1) and transcriptional co-activator p75, is the cellular binding partner of lentiviral integrase (IN) proteins. LEDGF accounts for the characteristic propensity of Lentivirus to integrate within active transcription units and is required for efficient viral replication. We now present a crystal structure containing the N-terminal and catalytic core domains (NTD and CCD) of HIV-2 IN in complex with the IN binding domain (IBD) of LEDGF. The structure extends the known IN-LEDGF interface, elucidating primarily charge-charge interactions between the NTD of IN and the IBD. A constellation of acidic residues on the NTD is characteristic of lentiviral INs, and mutations of the positively charged residues on the IBD severely affect interaction with all lentiviral INs tested. We show that the novel NTD-IBD contacts are critical for stimulation of concerted lentiviral DNA integration by LEDGF in vitro and for its function during the early steps of HIV-1 replication. Furthermore, the new structural details enabled us to engineer a mutant of HIV-1 IN that primarily functions only when presented with a complementary LEDGF mutant. These findings provide structural basis for the high affinity lentiviral IN-LEDGF interaction and pave the way for development of LEDGF-based targeting technologies for gene therapy.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 150 153 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 623 626 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 954 957 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1043 1046 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1154 1157 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Retroviruses crucially rely on insertion of their genomes into a host cell chromosome, and this process is carried out by the viral enzyme integrase. HIV and other lentiviruses also depend on LEDGF, a cellular chromatin-associated protein, which binds their integrase proteins and tethers them to a human chromosome. The interaction between integrase and LEDGF can potentially be exploited for directing integration of lentiviral vectors in gene therapy applications, as well as for development of antiretroviral drugs. Herein, we present a three-dimensional structure of a protein-protein complex containing a fragment of HIV integrase and the integrase-binding domain of LEDGF. Our structure elucidates the hitherto unknown LEDGF-integrase interface involving the amino terminal portion of the viral enzyme. Using a range of complementary approaches, we further show that these novel protein-protein contacts are essential for the function of LEDGF in HIV integration. The novel structural details will be very useful for the development of HIV inhibitors that target the integrase-LEDGF interaction. Furthermore, they enabled us to design a mutant of HIV integrase that depends on a reverse-engineered mutant of LEDGF, providing an inroad to the design of LEDGF-based lentiviral vector targeting strategies.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 274 277 274 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Lewinski1">[1]</xref>
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Craigie1">[2]</xref>
Integration of reverse transcribed viral cDNA into the host cell genome is an essential step in the retroviral life cycle. This process is catalyzed by integrase (IN), a virus-derived enzyme, which carries out two separate reactions acting on both cDNA termini (reviewed in [1],[2]). Firstly, 3'-processing takes place in the cytoplasm of the host cell, in which a di- or trinucleotide is hydrolytically removed from each cDNA end, exposing 3'-hydroxyl groups of invariant CA dinucleotides. The enzyme remains attached to both viral cDNA ends within a higher order pre-integration complex (PIC). The PIC is transported into the nucleus and, upon locating a suitable chromatin environment, the second reaction, strand transfer, ensues. During this step, the pair of hydroxyl groups produced during 3'-processing nick and join to opposing strands of the cellular DNA, four to six base pairs apart, depending on the retroviral genus. To complete the process, cellular enzymes repair the integration site, resulting in a stable provirus flanked by short duplications of the target DNA sequence.
###end p 7
###begin p 8
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Bushman1">[3]</xref>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Engelman2">[5]</xref>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Dyda1">[6]</xref>
###xml 370 372 370 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sub>
###xml 409 411 409 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 437 440 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Goldgur1">[7]</xref>
###xml 441 444 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Yang1">[8]</xref>
###xml 568 571 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cai1">[9]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Eijkelenboom1">[10]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Eijkelenboom2">[11]</xref>
###xml 682 686 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Lodi1">[12]</xref>
###xml 892 896 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Bao1">[13]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Li1">[15]</xref>
###xml 1061 1068 1061 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 1070 1074 1070 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wang1">[16]</xref>
###xml 1022 1027 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Retroviral INs share a conserved three domain organization, each containing a central catalytic core domain (CCD), flanked by N- and C-terminal domains (NTD and CTD) [3]-[5]. The CCD spans the most conserved region of IN and bears close structural homology to prokaryotic transposases [6]. The enzyme active site is comprised of three invariant acidic residues (the D,DX35E motif) that coordinate a pair of Mg2+ cations during catalysis [7],[8]. The NTD forms a three-helical bundle, which folds around a zinc atom coordinated by His and Cys residues of an HHCC motif [9],[10]. The CTD features an SH3-like fold, is rich in basic residues and is likely involved in DNA binding [11],[12]. Despite Herculean efforts directed towards characterization of this key antiviral drug target, the structure of a full-length retroviral IN remains elusive. The active form of retroviral IN is a tetramer [13]-[15], and a plausible tetramer model for the apoenzyme was proposed based on a crystal structure of a two-domain fragment of HIV-1 IN containing its NTD and CCD (INNTD+CCD) [16].
###end p 8
###begin p 9
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Engelman3">[17]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Yokoyama1">[18]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wu1">[20]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov1">[21]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Llano1">[24]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Llano1">[24]</xref>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Maertens1">[27]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Ciuffi1">[28]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Hombrouck1">[32]</xref>
###xml 853 857 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov3">[33]</xref>
###xml 858 862 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Vanegas1">[35]</xref>
###xml 1010 1014 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Maertens1">[27]</xref>
###xml 1015 1019 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov5">[36]</xref>
###xml 1176 1180 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Maertens1">[27]</xref>
###xml 1396 1404 1384 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1404 1408 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov3">[33]</xref>
###xml 313 318 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 320 325 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1037 1042 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1350 1355 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Lentiviral DNA integration critically depends on lens epithelium-derived growth factor (LEDGF) (reviewed in [17]). LEDGF tightly associates with chromatin and has been implicated in regulation of cellular gene expression, epigenetic chromatin modifications and apoptosis [18]-[20]. The host factor directly binds HIV-1, HIV-2, as well as other lentiviral INs and dramatically stimulates their strand transfer activity [21]-[24]. LEDGF tethers lentiviral IN to host chromatin in the nucleus [24]-[27] and plays a critical role in directing PICs to active genes during integration [28]-[32]. LEDGF contains a pair of small structural domains: an approximately92 residue PWWP domain at its N-terminus, responsible for binding to an as yet unidentified component of chromatin, and the IN binding domain (IBD, residues 347-429) within its C-terminal portion [33]-[35]. The CCD and NTD of IN were both implicated in LEDGF binding: while the CCD is minimally sufficient, the NTD is required for high affinity binding [27],[36]. Deletion of the HIV-1 IN NTD, or a mutation destabilizing zinc coordination within this domain (His-12 to Asn), greatly reduced the interaction with LEDGF [27]. A close homolog of LEDGF, hepatoma derived growth factor-related protein 2 (HRP2), contains conserved PWWP and IBD-like domains. Although HRP2 is able to interact with HIV-1 IN and stimulate its enzymatic activity in vitro[33], it remains to be established whether it plays a role in lentiviral integration.
###end p 9
###begin p 10
###xml 151 155 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov4">[34]</xref>
###xml 156 160 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov5">[36]</xref>
###xml 171 174 167 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCD</sub>
###xml 180 183 176 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 583 587 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov5">[36]</xref>
###xml 730 734 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 138 143 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The structure of the LEDGF IBD, composed of a pair of alpha-helical hairpins, has been determined both separately and in complex with the HIV-1 IN CCD [34],[36]. In the INCCD:LEDGFIBD complex, Ile-365 of LEDGF inserts into a hydrophobic pocket at the IN dimer interface. The interaction is further bolstered by additional hydrophobic interactions between IN residue Trp-131 and LEDGF Phe-406 and Val-408. Asp-366 of LEDGF plays an important role in protein-protein recognition, forming a pair of essential hydrogen bonds with the main chain amides of IN residues Glu-170 and His-171 [36]. Mutation of LEDGF Asp-366 to Asn ablated the interaction with all lentiviral INs tested so far, indicating a common mechanism of recognition [22]. In this work we extend the known lentiviral IN-LEDGF interface to include contacts between the IN NTD and the IBD of LEDGF. This part of the protein-protein interface is essential for high affinity binding and stimulation of concerted DNA integration, and allows designs of complementary pairs of IN and LEDGF mutants for practical uses in gene therapy.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Crystallization and Structure Determination
###end title 12
###begin p 13
###xml 105 112 105 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 122 125 122 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 256 263 256 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000259-t001">Table 1</xref>
###xml 844 845 844 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 848 849 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 882 900 882 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s002">Figure S1A and S1B</xref>
###xml 1093 1100 1093 1100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 1106 1109 1106 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 1239 1249 1239 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s002">Figure S1C</xref>
###xml 97 102 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 924 929 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1085 1090 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1171 1174 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To further characterize the interface between lentiviral INs and LEDGF, we obtained a complex of HIV-2 INNTD+CCD and LEDGFIBD by co-expression, and crystallized it in two forms. Although crystal form II diffracted to slightly lower resolution than form I (Table 1), it resulted in a higher quality structure. Firstly, form I displayed a higher degree of disorder and only three quarters of the asymmetric unit (ASU) could be unambiguously defined in electron density maps. Secondly, the twelve-fold non-crystallographic symmetry (NCS) in form II dramatically increased the observations:parameters ratio, resulting in a pseudo-high resolution structure. The structures observed in both crystal forms were overall equivalent, and the remainder of the paper will focus on form II. Snapshots of electron density for the CCD-IBD interface and Zn-His2Cys2 cluster of the NTD are shown in Figure S1A and S1B. Of note, all previous HIV-1 IN CCD crystal structures required Phe-185 to be mutated to Lys or His to improve protein solubility. Such a mutation was not necessary to crystallize the HIV-2 INNTD+CCD:LEDGFIBD complex. Therefore, our structure is the first to include an HIV IN CCD with a Phe residue naturally occurring at this position (Figure S1C).
###end p 13
###begin title 14
Data collection and refinement statistics.
###end title 14
###begin p 15
Values in parentheses are for the highest resolution shell.
###end p 15
###begin p 16
###xml 134 141 134 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 147 150 147 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 315 322 303 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 344 347 332 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 425 434 413 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1A</xref>
###xml 457 458 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 557 566 545 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1B</xref>
###xml 677 686 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1C</xref>
###xml 773 782 761 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1B</xref>
###xml 872 873 848 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 126 131 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 307 312 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Based on elution from calibrated gel filtration columns and velocity analytical ultracentrifugation experiments, the purified HIV-2 INNTD+CCD:LEDGFIBD complex behaved as a monodisperse species with a calculated molecular mass of approximately60 kDa (data not shown). This size is consistent with a dimer of HIV-2 INNTD+CCD plus one or two LEDGFIBD molecules, closely matching the basic building unit observed in the crystal (Figure 1A, referred to as the IN2LEDGF substructure). The substructure assembles further into closed trimers with a three-fold NCS (Figure 1B), and four such trimers accrue in the ASU to form a spherical structure containing 24 IN and 12 LEDGF chains (Figure 1C). The trimer is held primarily via IN-IN (CCD-CCD, NTD-CCD and NTD-NTD) interactions (Figure 1B), and the total buried surface area between neighboring IN dimers is approximately2,000 A2.
###end p 16
###begin title 17
###xml 12 19 12 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 25 28 25 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 4 9 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
The HIV-2 INNTD+CCD:LEDGFIBD Structure and Multimeric Assemblies Found in the Crystal.
###end title 17
###begin p 18
###xml 10 11 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 55 62 55 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 93 96 93 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 503 504 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) The IN2LEDGF substructure, containing a dimer of INNTD+CCD and a single molecule of LEDGFIBD, the basic building unit of both crystal forms. IN chains are colored pale green and cyan, and LEDGF is pink. Zinc atoms are shown as gray spheres. Residues involved in IN-LEDGF interfaces and discussed in the text are shown as sticks and indicated with arrowheads. (B) The closed trimer of IN2LEDGF substructures. Colors and labels as in (A). (C) Stereo view of the higher order assembly involving four IN2LEDGF trimers representing the entire ASU of crystal form II. Colors as in (A).
###end p 18
###begin title 19
The IN-LEDGF Interface and the Role of the IN NTD
###end title 19
###begin p 20
###xml 31 32 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 103 104 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 338 341 314 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCD</sub>
###xml 347 350 323 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 408 412 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov5">[36]</xref>
###xml 852 861 828 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s003">Figure S2</xref>
###xml 877 881 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 882 886 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov5">[36]</xref>
###xml 124 129 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 134 139 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 263 268 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 330 335 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 526 531 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 573 578 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 610 615 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 986 991 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 996 1001 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1101 1106 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1131 1136 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A total of approximately1,450 A2 of molecular surface is buried at the IN-LEDGF interface within the IN2LEDGF substructure. HIV-1 and HIV-2 INs share approximately60% amino acid sequence identity over the span of their CCDs. Accordingly, the contacts between the HIV-2 IN CCD and the IBD are very similar to those observed in the HIV-1 INCCD:LEDGFIBD structure, and have been extensively discussed elsewhere [36]. Significant changes to this part of the interface occur due to amino acid replacement at positions 128 and 129: HIV-2 encodes Met and Val, respectively, while HIV-1 carries Ala in both cases. The HIV-2 residues are nevertheless involved in similar hydrophobic interactions: the Met-128 side chain packs against Leu-368, Phe-406, and Val-408 of LEDGF, while Val-129 contributes to the hydrophobic pocket that buries LEDGF residue Ile-365 (Figure S2). As predicted [22],[36], the critical LEDGF Asp-366 residue forms a bidentate hydrogen bond to the same backbone amides in HIV-2 and HIV-1 INs, even though the side chains at these positions differ between viruses (Asn-170 and Thr-171 in HIV-2; Glu-170 and His-171 in HIV-1).
###end p 20
###begin p 21
###xml 45 49 45 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Maertens1">[27]</xref>
###xml 469 478 461 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g002">Figure 2A</xref>
###xml 847 848 839 840 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In agreement with prior biochemical analyses [27], the NTD of IN makes extensive contacts with LEDGF. A constellation of acidic residues on the first helix (alpha1) of the NTD (Glu-6, Glu-10, and Glu-13) faces positively charged residues on the alpha4 helix of the IBD (Lys-401, Lys-402, Arg-404, and Arg-405). Side-chains of LEDGF residues Lys-401, Arg-404, and Arg-405 are well ordered, and a well-defined salt bridge involves IN residue Glu-10 and Arg-405 of LEDGF (Figure 2A). The remaining side chains show varying degrees of order and appear to contribute to the overall charges of the interacting faces. The closely positioned and highly conserved IN residue Glu-11 is not involved in the interface and instead interacts with Lys-25 and Lys-186 of the same IN chain, supporting NTD structural integrity and hence overall stability of the IN2LEDGF substructure.
###end p 21
###begin title 22
Details of the NTD-IBD Interface.
###end title 22
###begin p 23
###xml 219 224 <span type="species:ncbi:9606">human</span>
###xml 226 231 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 236 241 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 260 263 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 265 269 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 271 274 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 439 444 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 449 454 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
(A) The acidic IN residues and basic LEDGF residues are shown as sticks. The 2Fo-Fc electron density map, contoured at 1sigma, is shown in pale blue. (B) Partial amino acid sequence alignment including residues 1-17 of human (HIV-1 and HIV-2) and non-primate (BIV, EIAV, FIV, and MVV) lentiviral INs. Conserved residues are shown in bold; His-12 and His-16 of the invariant HHCC motif are highlighted in yellow. Acidic residues known (for HIV-1 and HIV-2) or proposed to interact with the positively charged face of the IBD are orange.
###end p 23
###begin p 24
###xml 145 155 145 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 220 229 220 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g002">Figure 2B</xref>
###xml 869 873 865 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 874 878 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Llano1">[24]</xref>
###xml 879 883 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov3">[33]</xref>
###xml 884 888 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov4">[34]</xref>
###xml 73 76 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 232 261 <span type="species:ncbi:11673">Feline immunodeficiency virus</span>
###xml 263 266 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 278 289 <span type="species:ncbi:11741">visna virus</span>
###xml 291 294 <span type="species:ncbi:11741">MVV</span>
Acidic residues at IN positions 6, 10, and 13 are highly conserved among HIV isolates, and those at positions 10 and 13 tend to be acidic within Lentivirus, whose members retain at least one of the two negative charges (Figure 2B). Feline immunodeficiency virus (FIV) and maedi-visna virus (MVV) INs that lack negative charges at positions 10 and 13, respectively, contain additional acidic residues (Glu-7 and/or Glu-9), which should preserve the negative charge of the NTD face. Overall, lentiviral INs maintain two or more acidic residues within alpha1 of their NTDs, which can be predicted to contribute to the interaction with the positive face of the IBD. Conversely, the complementary basic residues are conserved among all known LEDGF and HRP2 orthologs, with some variation only at the position corresponding to LEDGF Arg-405, where Arg or Lys is accommodated [22],[24],[33],[34]. Of note, although some INs from nonlentiviral genera contain acidic residues at positions corresponding to residues 10 or 13 of lentiviral INs, these residues are not conserved within or among these genera (data not shown).
###end p 24
###begin p 25
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 494 501 494 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wang1">[16]</xref>
###xml 517 527 517 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3B</xref>
###xml 636 646 636 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3B</xref>
###xml 683 693 683 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3B</xref>
###xml 770 779 770 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3</xref>
###xml 805 806 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 834 844 834 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3A</xref>
###xml 921 922 921 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 972 981 972 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1B</xref>
###xml 486 491 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The pair of NTDs belonging to the IN dimer of the IN2LEDGF substructure exist in equivalent orientations with respect to the CCD dimer and are supported by contacts with the CCDs involving three salt bridges (Glu-11:Lys-186, Lys-20:Asp-193, and Glu-21:Arg-188) as well as hydrophobic stacking interactions involving Lys-14 and Tyr-15 of the NTD and Trp-131, Trp-132, and Lys-186 of the CCD. An almost identical NTD-CCD interface was observed in the crystal structure of the uncomplexed HIV-1 INNTD+CCD tetramer [16] (Figure S3B, discussed in more detail below). Notably, the interface was formed between a CCD of one IN dimer (green in Figure S3B) and an NTD from another (yellow in Figure S3B), and so the two structures present an interesting case of domain swapping (Figure S3). The other NTD of the IN2LEDGF substructure (cyan in Figure S3A) is important in forming the closed trimers as it interacts with a second IN2LEDGF module through its A chain NTD and the IBD (Figure 1B).
###end p 25
###begin title 26
The NTD-IBD Interface Is Critical for the High Affinity IN-LEDGF Interaction and Affords Functional Charge Reversal of Opposing Molecular Faces
###end title 26
###begin p 27
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov5">[36]</xref>
###xml 597 606 597 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1B</xref>
###xml 641 642 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 863 867 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Maertens1">[27]</xref>
###xml 968 977 968 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g003">Figure 3A</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Burke1">[37]</xref>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 1129 1133 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov4">[34]</xref>
###xml 1179 1188 1179 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g003">Figure 3A</xref>
###xml 1337 1370 1337 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g003">Figure 3A, lanes 5, 6, 11, and 12</xref>
###xml 691 696 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 698 703 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 740 769 <span type="species:ncbi:11657">bovine immunodeficiency virus</span>
###xml 771 774 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 777 780 <span type="species:ncbi:11741">MVV</span>
###xml 786 816 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 818 822 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 949 954 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1169 1174 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1316 1321 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1326 1331 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1567 1572 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The domain-domain interfaces observed in the crystal structure were targeted by mutagenesis to investigate their functional relevance. Three LEDGF mutants were designed to eliminate or reverse the positive charges facing the IN NTD: K401A/K402A/R405A (AAA), K401E/K402S/R405E (ESE), and K401E/K402E/R405E (EEE). The K360E mutation targeted a salt bridge from LEDGF residue Lys-360 to IN Asp-167 within the IBD-CCD interface [36], and K392E was made to disrupt a potential interaction between Lys-392 and Glu-6 within the secondary NTD-IBD interface that contributes to substructure trimerization (Figure 1B). The mutants were tested in a His6-tag pull-down assay for binding to the INs from HIV-1, HIV-2, and three nonprimate lentiviruses (bovine immunodeficiency virus [BIV], MVV, and equine infectious anemia virus [EIAV]). Consistent with earlier reports [22],[27], wild type (WT) LEDGF was pulled down by all WT lentiviral INs, but not with the HIV-1 H12N mutant (Figure 3A). His-12 is involved in zinc coordination and is, therefore, critical for structural integrity of the NTD [37]. Also in agreement with prior work [22],[34], D366N LEDGF did not interact with HIV-1 IN (Figure 3A) or any of the remaining INs (data not shown). Mutations reversing the positively charged face of the IBD disrupted binding to HIV-1 and HIV-2 INs (Figure 3A, lanes 5, 6, 11, and 12), and only very weak binding was detected for AAA LEDGF (lanes 4 and 10). Furthermore, the EEE mutations ablated the interaction with nonprimate lentiviral INs (lanes 14, 16, 18; data not shown). HIV-1 IN binding to LEDGF mutant K360E was also affected, albeit to a lesser degree (lane 7), while K392E was pulled down most efficiently of all LEDGF mutants tested (lane 8).
###end p 27
###begin title 28
Functional Importance of the NTD-IBD Charge-Charge Interface for the Lentiviral IN-LEDGF Interaction.
###end title 28
###begin p 29
###xml 131 132 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Rahman1">[38]</xref>
###xml 586 599 583 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 725 728 719 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 149 154 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 174 179 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 184 189 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 194 197 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 202 205 <span type="species:ncbi:11741">MVV</span>
###xml 213 217 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 456 461 <span type="species:ncbi:4932">Yeast</span>
###xml 586 599 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 673 678 <span type="species:ncbi:4932">yeast</span>
(A) Pull down experiments. Non-tagged WT, D366N, AAA, ESE, EEE, K360E, or K392E LEDGF proteins were incubated with C-terminally His6-tagged forms of HIV-1 IN mutant H12N, WT HIV-1 IN, HIV-2 IN, BIV IN, MVV IN, or EIAV IN (as indicated) in the presence of Ni-NTA agarose. Bound proteins were separated in 11% sodium dodecyl sulfate polyacrylamide gels and visualized with Coomassie Blue. Input quantities of LEDGF proteins are shown below the main gel. (B) Yeast two-hybrid analyses. The IN-LEDGF interaction assay [22],[38] is based on transactivation of the beta-galactosidase gene in S. cerevisiae indicator cells Y187. Relative beta-galactosidase activities produced by yeast co-transformed with the indicated IN and LEDGFIBD mutants are shown on a log scale, with 100% corresponding to the WT bait/WT prey condition. The background of the assay is defined by WT IN in the presence of empty prey vector and is shown as a gray line. Each bar represents a mean value; standard deviations were calculated based on results of quadruplicate measurements. Values exceeding the background are shown atop the bars.
###end p 29
###begin p 30
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Rahman1">[38]</xref>
###xml 570 579 567 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g003">Figure 3B</xref>
###xml 630 631 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1159 1168 1141 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g003">Figure 3B</xref>
###xml 1282 1291 1264 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g002">Figure 2B</xref>
###xml 1420 1429 1402 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g003">Figure 3B</xref>
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
###xml 158 163 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 440 445 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 945 950 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1182 1187 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The yeast two-hybrid technique proved more sensitive than pull down analyses when applied to weak interactions between IN and LEDGF mutants [38]. Full-length HIV-1 IN fused to the DNA binding domain of Gal4 serves as bait, and binding of the LEDGF IBD fused to Gal4 transcription activation domain is reflected by beta-galactosidase reporter gene activity. In this assay, LEDGF mutants K360E and K392E showed wild type levels of binding to HIV-1 IN, AAA bound at about 5% of WT, while similarly to D366N, the ESE and EEE mutants failed to interact at detectable levels (Figure 3B), essentially corroborating the results of the His6-tag pull down experiments. To demonstrate that these observations were not due to off-site effects such as defective folding or reduced expression of the LEDGF mutants and to validate the novel NTD-IBD interface further, the complementary IN residues were mutated, producing a reversed charge D6K/E10K/E13K (KKK) HIV-1 mutant. Impressively, KKK IN robustly interacted with the complementary EEE LEDGF mutant, generating approximately40% of WT-WT beta-galatosidase activity and furthermore, it failed to interact with WT LEDGF (Figure 3B). The double HIV-1 IN E10K/E13K (KK) mutant bearing charge reversals at the two more conserved acidic positions (Figure 2B) likewise gained the ability to interact with EEE LEDGF while displaying no detectable binding to the WT protein in this assay (Figure 3B).
###end p 30
###begin title 31
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The NTD-IBD Interface and LEDGF-Dependent HIV-1 IN Strand Transfer Activity
###end title 31
###begin p 32
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Sinha1">[39]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Valkov1">[41]</xref>
###xml 754 763 754 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4A</xref>
Whereas in vivo retroviral INs must integrate both viral cDNA ends in a concerted fashion, their recombinant forms are typically more proficient at half-site integration (i.e. integration of a single viral DNA end into one strand of a target DNA molecule). The relative efficiencies of concerted and half-site integration processes strongly depend on the in vitro reaction conditions, with parameters such as the length of the donor DNA, enzyme source and concentration, and presence of crowding agents greatly affecting the outcomes [22], [39]-[41]. The use of a short mimic of the viral cDNA end (referred to as donor DNA substrate) and supercoiled target DNA conveniently allows discrimination between products of concerted and half-site integration (Figure 4A).
###end p 32
###begin title 33
Effects of Mutations within the NTD-IBD Interface on LEDGF-Dependent Strand Transfer Activities of Lentiviral INs.
###end title 33
###begin p 34
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 972 976 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 1152 1159 1152 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s001">Text S1</xref>
###xml 1164 1173 1164 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s005">Figure S4</xref>
###xml 231 236 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 332 337 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 633 637 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 652 656 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1073 1078 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1191 1196 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Schematic of the reactions mediated by IN in the presence of circular DNA target: concerted integration results in a linear product while half-site reactions produce branched molecules (circular half-site and donor-donor). (B) HIV-1 IN activity under established conditions that favor half-site integration [22]. WT, KK, or KKK HIV-1 IN was incubated with 10 nM 500-bp donor DNA and supercoiled target DNA in the absence (lane 2) or presence (lanes 3-11) of WT, D366N, or EEE LEDGF. The products separated in an agarose gel were detected with ethidium bromide. Lane 1 contained a mock sample, with both IN and LEDGF omitted. (C) EIAV IN reactions. EIAV IN was incubated with 10 nM 225-bp donor DNA and supercoiled target DNA in the absence (lane 2) or presence (lanes 3 and 4) of WT or EEE LEDGF, as indicated. Lane 1 contained a mock sample without IN and LEDGF; lane 5 contained IN and WT LEDGF without donor DNA; lane 6 contained 10 ng of singly-nicked pGEM-9Zf(-) [22] as a migration standard for the open circular (o.c.) form of target DNA. (D) Enhanced concerted HIV-1 integration assay using an elevated input of donor DNA (for details, see Text S1 and Figure S4). WT, KK, or KKK HIV-1 IN was incubated with 0.5 microM pre-processed 32-bp donor and supercoiled target DNA in the presence of WT, D366N, AAA, ESE, EEE, K360E, or K392E LEDGF. Migration positions of various DNA species (size standards, supercoiled [s.c.] and o.c. target, donor, and reaction products) are indicated.
###end p 34
###begin p 35
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov1">[21]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Raghavendra1">[42]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Pandey1">[43]</xref>
###xml 258 263 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
LEDGF robustly promotes the strand transfer activities of divergent lentiviral INs in vitro, although the fidelity of LEDGF-mediated strand transfer varies for the different INs [21],[22]. Intriguingly, while simulating half-site strand transfer activity of HIV-1 IN under all reported conditions, the host factor has the capacity of to either inhibit [42] or bolster [43] its concerted integration activity.
###end p 35
###begin p 36
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 180 197 180 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4B, lane 3</xref>
###xml 383 399 371 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4A and 4B</xref>
###xml 515 532 503 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4B, lane 4</xref>
###xml 1354 1362 1342 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1383 1387 1371 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov3">[33]</xref>
###xml 1492 1496 1480 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov4">[34]</xref>
###xml 1498 1515 1486 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4B, lane 4</xref>
###xml 2047 2051 2035 2039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 105 110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 843 848 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1256 1261 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1551 1556 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1722 1727 <span type="species:ncbi:4932">yeast</span>
###xml 1992 1997 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the presence of 10 nM 500-bp donor substrate, 2.9 kb supercoiled plasmid DNA (pGEM), and WT LEDGF, WT HIV-1 IN carries out robust, predominantly half-site strand transfer [22] (Figure 4B, lane 3); half-site products migrate in agarose gels well above the open circular form of the target, while concerted integration products appear as linear (approximately4,000 bp) DNA species (Figure 4A and 4B). In agreement with earlier observations, the reaction was severely affected by the critical LEDGF D366N mutation (Figure 4B, lane 4). Despite greatly reduced binding affinity, the EEE LEDGF mutant retained the ability to stimulate half-site strand transfer activity, evident from accumulation of both donor-target and donor-donor products (lane 5). Concordantly, both WT and EEE LEDGF proteins stimulated the half-site activity of KK and KKK HIV-1 IN mutants. The KKK mutant, while significantly less active than WT IN, was somewhat more responsive to the mutant form of LEDGF (compare lanes 10 and 11). Based on these observations we conclude that the intact NTD-IBD interface and hence the full affinity of the IN-LEDGF interaction is not required for stimulation of half-site integration. This finding was not entirely unexpected, as HRP2, which binds HIV-1 IN with significantly lower affinity than LEDGF, is able to stimulate half-site integration in vitro to a similar extent [33]. Of note, because the ability of D366N LEDGF to bolster half-site strand transfer is severely repressed [34] (Figure 4B, lane 4), we argue that the stimulation of HIV-1 IN by LEDGF, and by EEE LEDGF, in particular, is strictly dependent on the direct protein-protein interaction. Concordantly, histidine and adenine auxotrophic AH109 yeast cells co-transformed with WT IN and EEE LEDGF Gal4 chimeras displayed a very slow growth phenotype on solid media lacking these nutrients, confirming a weak residual interaction (data not shown). In contrast, evidence for an interaction between D366N LEDGF and WT HIV-1 IN was not observed, even under these conditions [22].
###end p 36
###begin p 37
###xml 39 43 39 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 126 143 126 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4C, lane 3</xref>
###xml 678 685 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s001">Text S1</xref>
###xml 690 699 690 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s005">Figure S4</xref>
###xml 845 854 845 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4D</xref>
###xml 972 1004 972 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4D, compare lanes 4 and 5</xref>
###xml 1280 1300 1280 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4D, lanes 6&#8211;8</xref>
###xml 1356 1365 1356 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4B</xref>
###xml 1505 1530 1505 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4D, lanes 9 and 10</xref>
###xml 45 49 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 197 201 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 500 505 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 826 831 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In agreement with earlier observations [22], EIAV IN was highly competent for concerted integration in the presence of LEDGF (Figure 4C, lane 3). Notably, the concerted strand transfer activity of EIAV IN was severely reduced when EEE LEDGF was used (lane 4). At the same time, the trace levels of half-site activity were not significantly affected. These results indicated that the NTD-IBD interface bears a special significance for concerted lentiviral DNA integration. In the course of optimizing HIV-1 IN strand transfer conditions, we discovered that increasing donor DNA concentration greatly enhanced the yield of LEDGF-dependent concerted integration products (refer to Text S1 and Figure S4 for validation of the assay). This novel assay afforded a convenient means for studying the affects of mutations on LEDGF and HIV-1 IN function (Figure 4D). As expected, the D366N LEDGF mutant, severely defective for IN binding, failed to stimulate concerted integration (Figure 4D, compare lanes 4 and 5). Reaction products formed in the presence of AAA, ESE, and EEE LEDGF mutants show that successive addition of net negative charge at this location decreases the ability of the cofactor to stimulate concerted integration, with hardly any product visible with the EEE mutant (Figure 4D, lanes 6-8). However, in agreement with the data discussed above (Figure 4B), these mutants retained the ability to stimulate half-site integration. As expected, LEDGF mutants K360E and K392E displayed WT activity (Figure 4D, lanes 9 and 10).
###end p 37
###begin p 38
###xml 201 223 201 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g004">Figure 4D, lanes 13&#8211;16</xref>
###xml 448 453 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Significantly, both KK and KKK IN mutants gained concerted integration activity in the presence of EEE LEDGF. Furthermore, both IN mutants, and most dramatically KKK IN, favored the mutant LEDGF form (Figure 4D, lanes 13-16). These results confirm that the mutant proteins are properly folded and that the effects observed are due to the modification of the protein-protein interface. They also suggest a possibility to engineer a gain of function HIV-1 IN mutant, active specifically in the presence of a complementary mutant of the host factor.
###end p 38
###begin title 39
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The NTD-IBD Interface Is Important for LEDGF Cofactor Function During HIV-1 Infection
###end title 39
###begin p 40
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Shun1">[29]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Shun1">[29]</xref>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ledgf</italic>
###xml 852 861 852 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g005">Figure 5A</xref>
###xml 1008 1012 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Shun1">[29]</xref>
###xml 1316 1325 1304 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g005">Figure 5A</xref>
###xml 1461 1470 1449 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1B</xref>
###xml 1516 1525 1504 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g005">Figure 5A</xref>
###xml 1563 1571 1551 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
###xml 150 155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 197 203 <span type="species:ncbi:10090">murine</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
###xml 472 498 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 534 539 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 587 590 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 756 761 <span type="species:ncbi:10090">mouse</span>
###xml 1076 1079 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1163 1166 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To test the importance of the IBD-NTD interface in the context of viral replication, we used an established mouse LEDGF knockout model [29]. Although HIV-1 cannot complete its replication cycle in murine cells due to post-integration blocks, its reverse transcription and integration proceed normally and depend on LEDGF [29]. Ledgf-null mouse embryo fibroblasts (MEFs) transfected with a human LEDGF expression vector or its mutant forms were infected with single-round, vesicular stomatitis virus glycoprotein G (VSV-G)-pseudotyped HIV-1 vectors expressing a luciferase reporter gene (HIV-Luc), and the levels of luciferase activity in cell extracts were measured 44 h post infection. The WT and mutant LEDGF proteins were well-expressed, and endogenous mouse LEDGF protein, as predicted, was not detected in cells transfected with the empty vector (Figure 5A). WT LEDGF expression increased the level of knockout cell infection five to ten-fold as compared to cells carrying the empty vector. As expected [29], the D366N LEDGF mutant failed to stimulate the basal level of HIV-Luc infection. LEDGF AAA, K360E, and K392E by contrast supported similar levels of HIV-Luc infectivity as WT LEDGF, while its K401E/K402A/R405E (EAE, similar to ESE) and EEE mutants functioned at approximately25% and 10%, respectively (Figure 5A). An additional LEDGF mutant combining the EEE and K360E mutations, and therefore lacking the Lys-360:Glu-167 IBD-CCD salt bridge (E4, Figure 1B), supported the lowest level of infectivity (Figure 5A). These results tie in well with the in vitro interaction and activity data, extending the biological significance of the NTD-IBD interface.
###end p 40
###begin title 41
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
LEDGF Residues Lys-401, Arg-404, and Arg-405 Play a Crucial Role in HIV-1 Infection.
###end title 41
###begin p 42
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ledgf</italic>
###xml 49 52 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 406 409 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Relative infectivity of VSV G-pseudotyped WT HIV-Luc virus on Ledgf-null E2 MEFs transfected with human WT, AAA, EAE, EEE, E4, or D366N LEDGF expression vectors, as indicated. Infectivity of the virus in the presence of WT LEDGF was set to 100%; mean values and standard deviations combine data of two independent sets of transfections (each with infections performed in duplicate). (B) Infectivity of HIV-Luc bearing KK mutations in IN on E2 MEFs transfected with WT, EAE, or EEE LEDGF. Infectivity is expressed as a percentage of WT virus on the cells transfected with WT LEDGF. Western blots above the graphs show expression levels of LEDGF proteins and actin loading control.
###end p 42
###begin p 43
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Engelman4">[44]</xref>
###xml 836 844 836 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 915 924 915 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g005">Figure 5B</xref>
###xml 1078 1087 1078 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g005">Figure 5B</xref>
###xml 1221 1222 1219 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 327 332 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 623 626 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 945 948 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1246 1249 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Release and infectivity of HIV-1 mutants carrying substitutions at IN positions 6, 10, and 13 were impaired to various extents. The KKK variant was most affected, failing to support any appreciable infectivity under a variety of conditions. This result was not unexpected, as often subtler changes in IN grossly affect various HIV-1 replication steps [44]. The nature of the defects observed with mutant viruses will be elaborated elsewhere. As demonstrated above, the double mutant carrying substitutions at the more conserved NTD acidic positions (E10K/E13K) was able to functionally interact with EEE LEDGF. Although KK HIV-Luc supernatants harvested from transfected 293T cells contained approximately 30% of reverse transcriptase (RT) activity compared to WT, suggesting subtle release or maturation defects, in agreement with the in vitro data, this virus was infectious when presented with LEDGF EAE or EEE (Figure 5B). Significantly, KK HIV-Luc infectivity was negligible in the presence of WT LEDGF, generating luciferase levels comparable to the empty vector control (Figure 5B). In repeat experiments, the infectivity of the KK virus in the presence of LEDGF EEE varied between 3.5 and 40.8% (19.3+/-12.3% for n = 6 experiments) of WT HIV-Luc infectivity in the presence of WT LEDGF. These results confirm that modifications of the charge-charge NTD-IBD interface allow creation of viable gain of function IN mutants able to functionally interact with an engineered version of LEDGF.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 518 525 518 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 531 534 531 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-GanserPornillos1">[45]</xref>
###xml 1095 1096 1095 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1403 1407 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov6">[46]</xref>
###xml 510 515 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
In this work we extended the known lentiviral IN-LEDGF interface to include the interactions between the NTD of IN and the IBD of LEDGF. Since there is no evidence that the CTD of IN or LEDGF regions outside of the IBD are involved in the interaction, the contacts observed in our crystal structure may very well represent the entire IN-host factor interface. These novel structural details will invariably aid the development of inhibitors of the IN-LEDGF interaction. Intriguingly, both crystal forms of the HIV-2 INNTD+CCD:LEDGFIBD complex contained closed trimers of the IN2LEDGF substructure held together primarily by IN-IN contacts. Based on the three-fold symmetry of this assembly, we tentatively speculate that it could reflect packing arrangement of IN molecules within retroviral capsids, which too feature three-fold symmetry [45]. In both crystals the closed trimers further associated into a spherical particle containing twenty four IN chains, with their C-termini projecting inwards and the N-termini outwards. It remains to be determined if the higher order multimers of the IN2LEDGF substructure are biologically relevant. Such evidence could come, for example, by observing similar multimers in crystals of a divergent retroviral IN. Although we have not detected analogous large-sized complexes in solution, the calculated concentration of IN within retroviral capsids is very high [46], presenting an environment where it may very well adopt a paracrystalline state.
###end p 45
###begin p 46
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Bao1">[13]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Li1">[15]</xref>
###xml 147 154 147 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wang1">[16]</xref>
###xml 392 399 392 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 405 408 405 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wang1">[16]</xref>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wang1">[16]</xref>
###xml 678 696 678 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3A and S3B</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Rousseau1">[47]</xref>
###xml 905 912 905 912 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wang1">[16]</xref>
###xml 1271 1281 1271 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3C</xref>
###xml 1394 1404 1394 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3D</xref>
###xml 1589 1593 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Li1">[15]</xref>
###xml 1815 1823 1815 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1835 1839 1835 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Raghavendra1">[42]</xref>
###xml 1980 1989 1980 1989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000259.s004">Figure S3</xref>
###xml 2179 2183 2179 2183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Pandey1">[43]</xref>
###xml 2381 2385 2381 2385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Lesbats1">[48]</xref>
###xml 139 144 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 384 389 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 897 902 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1776 1781 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2513 2518 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2576 2580 <span type="species:ncbi:11665?1.0">EIAV</span>
Mounting experimental evidence suggests that the active form of retroviral IN is a tetramer [13]-[15]. Based on a crystal structure of the HIV-1 INNTD+CCD fragment, Craigie and colleagues proposed a plausible model for the synaptic IN tetramer (dimer of dimers) [16]. Notably, the positions of the IN NTDs relative to the CCD dimer and the supporting NTD-CCD contacts observed in our HIV-2 INNTD+CCD:LEDGFIBD complex were seen in the earlier structure, where the NTDs mediated contacts between IN dimers [16]. One significant difference is that in the tetramer model, the NTD occupying the position primed for the interaction with the IBD is donated by the other IN dimer [16] (Figure S3A and S3B). Such domain swapping is quite common, representing one of the mechanisms for homomeric protein-protein interactions [47]. However, it is important to note an ambiguity of the NTD assignments in the HIV-1 INNTD+CCD structure, which lacked appreciable electron density for the NTD-CCD linkers [16]. Nevertheless, the NTD-CCD interface observed in the two independent structures is almost certainly biologically relevant. If IN dimers do indeed swap their NTDs during tetramerization, the LEDGF binding platform would include a CCD dimer and an NTD from a separate IN dimer (Figure S3C). Alternatively, LEDGF binding to an IN dimer would lock one NTD in the orientation primed for tetramerization (Figure S3D). In either case, upon binding, the co-factor would enhance the thermodynamic stability of the tetramer. It is a tetramer of IN that mediates synapsis of a pair of donor DNA molecules [15] and, concordantly, the NTD-IBD contacts uncovered here are specifically required for concerted DNA integration. The model can also explain the surprising ability of LEDGF to inhibit HIV-1 concerted integration under some in vitro conditions [42]. LEDGF binding to a dimer of IN would fixate either one or both NTDs, preventing them from functionally interacting with a second IN dimer (Figure S3). Thus, the concentration of IN, LEDGF and donor DNA substrate in the reaction mixture, as well as the order of component addition significantly influence the outcome of the reaction (Ref. [43] and data not shown). Of note, one recent study suggested that IN must exist in a lower multimeric state, likely a dimer, before interacting with the donor DNA for proper synaptic complex formation [48]. The enhanced concerted integration assay described herein will be very useful in future biochemical and structural studies of HIV-1 IN. Furthermore, other lentiviral INs, and in particular EIAV IN, carry out very efficient LEDGF-dependent concerted integration utilizing oligonucleotide donor DNA substrates under similar reaction conditions (data not shown).
###end p 46
###begin p 47
###xml 106 116 106 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lentivirus</italic>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Ciuffi1">[28]</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Marshall1">[30]</xref>
###xml 696 700 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-HaceinBeyAbina1">[49]</xref>
###xml 872 880 862 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 880 884 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Ciuffi2">[50]</xref>
###xml 1316 1320 1306 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Yokoyama1">[18]</xref>
###xml 760 780 <span type="species:ncbi:10710">bacteriophage lambda</span>
###xml 821 826 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1351 1356 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Using complementary approaches we demonstrated that the NTD-IBD interface is important for the functional Lentivirus-host interaction. Compared to the lock-and-key CCD-IBD interface, the contacts involving the NTD are based on charge-charge interactions and therefore lend themselves to complementary reverse-charge engineering. Since LEDGF has been shown to target lentiviral integration to active transcription units [28]-[30], it has been speculated that modified versions of the host factor could be used to control integration site selection. Safety of retroviral vectors would be greatly improved if they could be directed towards specific pre-determined loci and away from proto-oncogenes [49]. In one recent work, a fusion of the DNA binding domain of bacteriophage lambda repressor and the IBD of LEDGF targeted HIV-1 integration nearby lambda operator sequences in vitro[50]. One fundamental problem can thwart practical application of such approaches. When delivered into the cell, the targeting factor, associated with a limited number of chromosomal loci, will have to compete with a vast excess of endogenous LEDGF for the incoming preintegration complex. Knockout or knockdown of endogenous LEDGF would unlikely be a practical or safe solution, especially considering its emerging role in epigenetics [18]. Here we demonstrated that an HIV-1 IN mutant carrying two reverse charge mutations within the NTD gained the ability to functionally interact with a modified version of LEDGF, while remaining basically unresponsive to the WT protein. Although the efficiency of the current system is somewhat modest, our results present a proof of principle that it is possible to engineer a viable complementary pair of IN and LEDGF mutants that could allow future development and practical applications of LEDGF-based lentiviral vector technologies.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
Recombinant DNA
###end title 49
###begin p 50
###xml 32 39 32 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 95 102 95 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 112 115 112 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 578 587 578 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XmaI/XhoI</italic>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 667 671 667 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HXB2</sub>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Turlure1">[51]</xref>
###xml 881 885 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Rahman1">[38]</xref>
###xml 1021 1024 1021 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 1192 1196 1192 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Shun1">[29]</xref>
###xml 1197 1201 1197 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Lu1">[52]</xref>
###xml 1289 1313 1289 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 1338 1342 1338 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Mossessova1">[53]</xref>
###xml 25 29 <span type="species:ncbi:11709?1.0">HIV2</span>
###xml 87 92 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 189 194 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 366 385 <span type="species:ncbi:12131">human rhinovirus 14</span>
###xml 490 494 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 534 539 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 606 609 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 623 626 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 662 665 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 714 718 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 791 796 <span type="species:ncbi:4932">yeast</span>
###xml 1035 1040 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1078 1083 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1136 1139 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1289 1313 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1369 1372 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 1391 1394 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
Compatible plasmids pCDF-HIV2-INNTD+CCD and pES-IBD-3C7 were used for co-expression of HIV-2 INNTD+CCD and LEDGFIBD in bacteria. To obtain the former, a fragment encoding residues 1-209 of HIV-2 IN was inserted between NcoI and BamHI sites of pCDF-Duet1 (Novagen); the latter was made by TA-cloning of a PCR fragment encoding LEDGF residues 347-471 with an internal human rhinovirus 14 (HRV14) 3 C protease cleavage site (LEVLFQGP, C-terminal to Val-435) into pET-SUMO (Invitrogen). pCPH6P-HIV1-IN, used for expression of full-length HIV-1 IN, was obtained by replacement of an XmaI/XhoI fragment encoding BIV IN in pCPH6P-BIV-IN [22] with a fragment coding for HIV-1HXB2 IN. Mutations were introduced into pCPH6P-HIV1-IN and pFT1-LEDGF [51] using the QuikChange procedure (Stratagene). For yeast two-hybrid assays, mutations were introduced into pCPY414-DBD-IN and pCPY426-AD-IBD [38] by swapping wild type IN and LEDGF fragments with their mutant forms. For virus infectivity assays, mutations were introduced into the env-deficient HIV-1 proviral clone pNLX.Luc(R-) encoding HIV-1 with a gene for firefly luciferase in place of Nef (HIV-Luc) and pIRES2-eGFP-LEDGF, as previously described [29],[52]. For production of SUMO protease, a PCR fragment encoding the catalytic core domain of Saccharomyces cerevisiae Ulp1 (residues 403-621) [53] was subcloned into pCPH6P-BIV-IN, replacing the BIV IN coding sequence to give pCPH6P-Ulp1CD. All DNA constructs made in this work were verified by sequencing to avoid inadvertent mutations.
###end p 50
###begin title 51
Protein Expression and Purification
###end title 51
###begin p 52
###xml 18 25 18 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 64 80 64 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 128 135 128 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 316 317 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 763 764 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 945 946 900 901 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 10 15 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 64 80 <span type="species:ncbi:562">Escherichia coli</span>
###xml 121 125 <span type="species:ncbi:11709?1.0">HIV2</span>
To obtain HIV-2 INNTD+CCD:LEDGFIBD complex for crystallography, Escherichia coli PC2 cells [22] co-transformed with pCDF-HIV2-INNTD+CCD and pES-IBD-3C and grown in LB medium in the presence of 50 microg/ml kanamycin and 100 microg/ml spectinomycin to an A600 of approximately1.0 were supplemented with 50 microM ZnCl2 and induced with 0.3 mM isopropyl-beta-D-thiogalactopyranoside. Following 4 h induction at 22degreesC, cells were harvested and stored at -80degreesC. For purification, cells were lysed by sonication in 1 M NaCl, 20 mM imidazole, 0.2 mM PMSF, 50 mM Tris-HCl, pH 7.4, and the protein complex was captured on Ni-NTA agarose (Qiagen). Following extensive washing the protein was eluted in 1 M NaCl, 200 mM imidazole, 50 mM Tris-HCl, pH 7.4. The His6-SUMO tag was cleaved by overnight incubation with SUMO protease at 7degreesC in the presence of 2 mM DTT. The sample was diluted with four volumes of 1 M NaCl, and the released His6-SUMO was depleted by absorption onto a 5-ml HisTrap column (GE Healthcare). Residues C-terminal to the IBD were removed by overnight digestion with HRV14 3 C protease in the presence of 10 mM DTT at 7degreesC. The complex was then purified by chromatography over a Superdex-200 column (GE Healthcare) in 1 M NaCl, 50 mM Tris-HCl, pH 7.4, concentrated to 17 mg/ml, supplemented with 10 mM DTT and 10% glycerol, and flash-frozen in liquid nitrogen.
###end p 52
###begin p 53
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Turlure1">[51]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Mossessova1">[53]</xref>
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 136 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
###xml 264 268 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 301 306 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 308 313 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 315 318 <span type="species:ncbi:11657?0.8659217877094972">BIV</span>
###xml 320 324 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 330 333 <span type="species:ncbi:11741">MVV</span>
Non-tagged wild type and mutant HIV-1 IN proteins used in strand transfer assays were produced in PC2 cells transformed with pCPH6P-HIV1-IN or its mutant forms as previously described [22]. The His6-tag was removed by digestion with HRV14 3 C protease. Non-tagged EIAV IN and C-terminally His6-tagged HIV-1, HIV-2, BIV, EIAV, and MVV IN proteins have been reported [22]. Wild type and mutant LEDGF proteins were made according to [51]. The SUMO protease Ulp1 catalytic domain fragment was produced in PC2 cells transformed with pCPH6P-Ulp1CD and purified as described in [53].
###end p 53
###begin title 54
Crystallization and Structure Determination
###end title 54
###begin p 55
###xml 114 121 104 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 127 130 117 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IBD</sub>
###xml 404 405 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 782 783 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1017 1023 971 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOSFLM</italic>
###xml 1023 1027 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Leslie1">[54]</xref>
###xml 1032 1037 986 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCALA</italic>
###xml 1037 1041 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Evans1">[55]</xref>
###xml 1054 1058 1008 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCP4</italic>
###xml 1067 1071 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-CCP41">[56]</xref>
###xml 106 111 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Vapor diffusion crystallization experiments were set up at 18degreesC in hanging drops by mixing 1 microl HIV-2 INNTD+CCD:LEDGFIBD complex at a concentration of 4 mg/ml in 20 mM Tris-HCl, pH 7.4, 300 mM NaCl, and 2 mM dithiothreitol (DTT) with 1 microl reservoir solution containing either 2.6 M sodium acetate, 0.1 M KI and 0.1 M Bis-Tris propane-HCl, pH 7.0 (form I) or 2.5 M sodium acetate, 10 mM MgCl2, and 0.1 M Bis-Tris propane-HCl, pH 7.0 (form II). Crystals of form I appeared within 24 h and reached the maximum size of approximately300x300x300 microm within 10-30 days, while those of form II appeared within a week and grew over several months to approximately150x150x150 microm. Both types of crystals were cryoprotected in 25% glycerol, 2.6 M sodium acetate, 10 mM MgCl2, 0.1 M Bis-Tris propane-HCl, pH 7.0. Diffraction data were collected to a resolution of 3.0 A (form I) and 3.2 A (form II) at the European Synchrotron Radiation Facility (ESRF) beamline ID23-1 at 100 K. The data were processed using MOSFLM[54] and SCALA[55] part of the CCP4 project [56].
###end p 55
###begin p 56
###xml 209 215 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOLREP</italic>
###xml 215 219 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Vagin1">[57]</xref>
###xml 502 506 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Wang1">[16]</xref>
###xml 507 511 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov5">[36]</xref>
###xml 870 876 847 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">REFMAC</italic>
###xml 876 880 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Murshudov1">[58]</xref>
###xml 885 891 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHENIX</italic>
###xml 891 895 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Adams1">[59]</xref>
###xml 988 992 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COOT</italic>
###xml 992 996 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Emsley1">[60]</xref>
Crystal form I belonged to the space group P321 with unit cell parameters a = b = 210.5 A, c = 162.6 A, alpha = beta = 90degrees, and gamma = 120degrees. The structure was solved by molecular replacement with MOLREP[57] using three individual search models in the following order. First, three dimers of CCDs (chains A and B from 2b4j) were located, forming a trimer of dimers, followed by a single IBD molecule (chain C from 2b4j) per CCD dimer, and finally the NTDs (chain A residues 1-45 from 1k6y) [16],[36]. After rigid body refinement, it became clear that a fourth IN dimer with corresponding IBD molecule was located out of the plane of the original trimer of dimers, and that this new dimer formed a similar trimer of dimers via the crystallographic three-fold axis. The ASU contained twelve protein chains and over 70% solvent. The structure was refined using REFMAC[58] and PHENIX[59], including translation, libration and screw (TLS) refinement, with manual model building in COOT[60].
###end p 56
###begin p 57
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 258 262 241 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">free</sub>
###xml 331 338 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SFTOOLS</italic>
###xml 352 356 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCP4</italic>
###xml 371 375 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-CCP41">[56]</xref>
###xml 430 436 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHASER</italic>
###xml 436 440 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-McCoy1">[61]</xref>
###xml 607 613 590 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHENIX</italic>
###xml 643 649 626 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">REFMAC</italic>
###xml 897 904 880 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000259-t001">Table 1</xref>
Form II crystals belonged to the space group P212121 with unit cell parameters a = 201.4 A, b = 202.5 A, c = 280.5 A, and alpha = beta = gamma = 90degrees. A high degree of NCS was expected due to the large unit cell. Therefore, to reduce potential bias in Rfree estimation, the test reflection set was chosen in thin shells using SFTOOLS, part of the CCP4 program suite [56]. The structure was solved by molecular replacement in PHASER[61], using a search model containing the dimeric IN assembly plus an associated LEDGF chain as observed in form I. The structure was refined using simulated annealing in PHENIX and restrained refinement in REFMAC, imposing tight 12-fold NCS restraints. Positive Fo-Fc density was observed at the known binding sites for zinc and magnesium and the corresponding atom was added to the structure. Details on data collection and refinement statistics are shown in Table 1. Diffraction data and the resulting structure derived from crystal form II were deposited to the protein databank (PDB ID 3f9k), and those for form I are available upon request.
###end p 57
###begin title 58
Protein-Protein Interaction and Strand Transfer Activity Assays
###end title 58
###begin p 59
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov4">[34]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Rahman1">[38]</xref>
###xml 116 129 116 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 495 521 495 521 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGACTGAGGGGCCTGAAATGAGC</named-content>
###xml 522 558 522 558 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTGTTGGGTGTTCTTCACCGCCCC GCGAGCT</named-content>
###xml 587 610 587 610 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTAAGTTGGGTAACGCCAGG</named-content>
###xml 611 636 611 636 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACT GTAGGATCTCGAACAGAC</named-content>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov6">[46]</xref>
###xml 23 28 <span type="species:ncbi:4932">yeast</span>
###xml 116 129 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 246 251 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 256 260 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 390 395 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 647 651 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 683 687 <span type="species:ncbi:11665?1.0">EIAV</span>
His6-tag pull-down and yeast two-hybrid assays were performed as described previously [22],[34],[38]. The indicator S. cerevisiae strains Y187 and AH109 were from BD Biosciences. Untagged, recombinant INs were used in all strand transfer assays. HIV-1 and EIAV integration assays with the respective 500-bp and 225-bp RU5 donor DNA substrates were carried out as previously described [22]. HIV-1 donor DNA was obtained as a PCR product using Pfu DNA polymerase (Stratagene) with the primer pair 5'-GGACTGAGGGGCCTGAAATGAGC/5'-ACTGTTGGGTGTTCTTCACCGCCCC GCGAGCT and pU3U5 template; primers 5'-TTAAGTTGGGTAACGCCAGG/5'-ACT GTAGGATCTCGAACAGAC and pU3U5-EIAV template were used to make the EIAV donor [22],[46].
###end p 59
###begin p 60
###xml 106 139 106 139 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTTTAGTCAGTGTGGAAAATCTCTAGCA</named-content>
###xml 143 178 143 178 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT</named-content>
###xml 183 219 183 219 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTGCTAGAGATTTT CCACACTGACTAAAAGG</named-content>
###xml 540 541 524 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 569 570 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 282 287 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 331 336 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 785 790 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For enhanced HIV-1 concerted integration assays, donor DNA was prepared by annealing DNA oligonucleotides 5'-CCTTTTAGTCAGTGTGGAAAATCTCTAGCA or 5'-CCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT and 5'-ACTGCTAGAGATTTT CCACACTGACTAAAAGG to create a 32 bp mimic of the pre-processed or non-processed HIV-1 U5 cDNA terminus, respectively. Two microl HIV-1 IN in 750 mM NaCl, 2 mM DTT, 20 mM Tris-HCl, pH 7.4 (DB) was added to 36 microl master mix containing 0.55 microM donor DNA and 0.30 microg supercoiled pGEM-9Zf(-) target DNA in 25.3 mM NaCl, 5.5 mM MgSO4, 11 mM DTT, 4.4 microM ZnCl2, 22 mM HEPES-NaOH, pH 7.4. Following a 3-5 min pre-incubation at room temperature, reactions were supplemented with 2 microl LEDGF in DB and allowed to proceed at 37degreesC for 30 min. The final concentrations of HIV-1 IN and LEDGF were both 0.6 microM. The reactions were stopped by addition of 25 mM EDTA and 0.5% SDS. The products deproteinized by digestion with 30 microg Proteinase K for 1 h at 37degreesC and ethanol precipitation were resolved by electrophoresis in 1.5% agarose gels and detected using ethidium bromide.
###end p 60
###begin p 61
###xml 386 387 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 423 426 405 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 434 438 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Cherepanov2">[22]</xref>
###xml 459 466 437 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 682 685 648 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 459 466 <span type="species:ncbi:562">E. coli</span>
For sequencing analysis, reaction products migrating as a band of approximately3 kb were isolated from a 1.5% agarose gel and converted into fully double stranded forms by treatment with Phi29 DNA polymerase (New England Biolabs) in the presence of 500 microM dNTPs. The DNA was then 5'-phosphorylated and ligated to a blunt-ended 1.2-kb PCR fragment spanning the Tn5 aminoglycoside-3'-O-phosphotransferase gene flanked by KpnI sites [22]. Competent DH5alpha E. coli cells were transformed with the ligation mixture. Plasmids were isolated from individual kanamycin-resistant colonies, and those releasing fragments of expected sizes (approximately3 and 1.2 kb) upon digestion with KpnI, were sequenced using primers annealing within the Tn5-derived fragment.
###end p 61
###begin title 62
Infectivity Assays
###end title 62
###begin p 63
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Shun1">[29]</xref>
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Shun2">[62]</xref>
###xml 197 199 197 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ledgf</italic>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000259-Shun1">[29]</xref>
###xml 103 106 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 269 <span type="species:ncbi:10090">mouse</span>
###xml 313 328 <span type="species:ncbi:10633">simian virus 40</span>
###xml 643 646 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Single cycle infectivity assays were done as described elsewhere [29],[62]. Briefly, VSV-G-pseudotyped HIV-Luc carrying various IN alleles generated by transfecting 293T cells were titered using a 32P-based reverse transcriptase (RT) assay. The Ledgf-null E2(-/-) mouse embryo fibroblasts (MEFs) transformed with simian virus 40 large T antigen were previously described [29]. Cells transfected with empty, WT, or mutant LEDGF pIRES2-eGFP expression vectors and sorted by FACS to enrich the GFP-positive population were lysed for western blot analyses or plated for infections. 10 h after plating, the cells were infected with equal RT-cpm of HIV-Luc variants. Cells were lysed and luciferase activity relative to the total protein content of the lysates was measured 44 h post infection.
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Validation of LEDGF-Dependent Concerted HIV-1 IN Strand Transfer Activity
###end p 65
###begin p 66
(0.04 MB DOC)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 235 242 <span type="species:ncbi:9031">chicken</span>
###xml 624 629 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Examples of Electron Density for Different Regions of the Structure. (A) The CCD-IBD interface with crucial LEDGF residues Asp-366 and Ile-365 labeled. In all panels the 2fo-fc electron density contoured at 1.5 sigma level is shown as chicken wire in blue, and protein residues are represented as sticks. Coloring of carbon atoms is related to their chain (green - IN chain A, cyan - IN chain B, and pink - LEDGF chain C); nitrogen, oxygen, and sulfur are blue, red, and yellow, respectively. (B) The HHCC motif, including a coordinated Zn atom (gray sphere). (C) The native side-chain and corresponding electron density of HIV-2 IN residue Phe-185.
###end p 68
###begin p 69
(6.93 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 36 41 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Stereo Image Showing Details of the HIV-2 IN CCD-LEDGF IBD Interface. Interacting residues are shown as sticks and are labeled. Cartoon and carbon atoms are colored according to their chain (green - IN chain A, cyan - IN chain B, and pink - LEDGF chain C). Hydrogen bonds between Asp-366 and the main chain amides of IN residues Asn-170 and Thr-171 are shown as black dashes.
###end p 71
###begin p 72
(1.28 MB TIF)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 132 141 132 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1A</xref>
###xml 194 195 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 262 271 262 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000259-g001">Figure 1B</xref>
###xml 315 322 315 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTD+CCD</sub>
###xml 307 312 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A Model for IN Tetramerization via Inter-Dimer NTD Swapping. (A) The IN2LEDGF substructure is shown in green, cyan, and pink (as in Figure 1A). The NTD colored dark blue belongs to a separate IN2LEDGF unit, its contacts with the IBD stabilize the closed trimer (Figure 1B). (B) The structure of uncomplexed HIV-1 INNTD+CCD (PDB ID 1k6y), crystallized as a tetramer (dimer of dimers). One dimer of IN (green and cyan) is shown with the CCDs in the same orientation as in panel A, with the tetramer completed by the dimer colored yellow and orange. The yellow NTD enclosed in an oval is in the same position and orientation as the green NTD in (A), while the orange NTD (circled) is in a similar position but a different orientation to the dark blue NTD in (A). (C) Schematic diagram of the proposed assembly and domain interactions within the active synaptic complex (IN CTDs are not shown). Coloring of the IN and IBD molecules is same as in (A) and (B); large circles represent the IN CCDs, small circles the NTDs, and parallelograms the IBDs. NTDs are connected to the same-chain CCDs by flexible hinges (black curves). Association of the two dimers during synaptic complex assembly involves a swap of an NTD from each dimer to interact with a CCD from the opposing dimer. When loaded, LEDGF would engage the CCDs from one dimer and an NTD from another, effectively stabilizing the complex. Further, it is also speculatively possible that the other NTD interacts with the IBD, as seen with the dark blue NTD in (A). (D) Alternative model for the assembly of the synaptic complex in which there is no NTD swap. In this case the IBD of LEDGF stabilizes the synaptic complex by locking the NTDs in the correct orientation for tetramerization.
###end p 74
###begin p 75
(0.81 MB JPG)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 315 320 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 411 416 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 483 488 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 624 629 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1622 1627 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Validation of LEDGF-Dependent Concerted HIV-1 IN Strand Transfer Activity. (A) Increasing input of donor DNA favors concerted integration. Lane 1 contains a mock sample, where IN and LEDGF were omitted; lane 2 shows activity in the absence of LEDGF; lane 3 contained both LEDGF and IN, but no donor DNA. Lanes 4-9: HIV-1 IN was incubated with 1 microM-4 nM (as indicated) blunt 32-bp donor DNA mimicking the U5 HIV-1 cDNA end and supercoiled target DNA in the presence of LEDGF. (B) HIV-1 IN strand transfer inhibitor MK0518 (Raltegravir) effectively blocks accumulation of full- and half-site reaction products. Lanes 4-9: HIV-1 IN was incubated with 0.5 microM pre-processed 32-bp donor DNA in the presence of LEDGF and MK0518 at final concentrations of 1,400 microM (lane 4), 140 microM (lane 5), 14 microM (lane 6), 1.4 microM (lane 7), 0.14 microM (lane 8), or 0.014 microM (lane 9). Almost complete suppression of half- and full-site integration is achieved at 1.4 microM MK0518, which is comparable to the concentration of IN (0.8 microM) used in this experiment. The inhibitor was not present in lane 3. Lane 1 contained a mock sample without IN and LEDGF; the cofactor was omitted from the reaction in lane 2. Migration positions of DNA size standards, DNA substrate, open circular (o.c.), and supercoiled (s.c.) target DNA forms, half- and concerted (full-site) products are indicated. (C) 2-D agarose gel analysis of reaction products formed under conditions of enhanced concerted integration. DNA species obtained from incubation of pre-processed 32-bp donor DNA and supercoiled pGEM target in the presence of HIV-1 IN and LEDGF (lane 1), IN alone (lane 2), or in the absence of both proteins (lane 3) were separated in 0.6% agarose along with 1-kb ladder DNA (lane L) (top gel). A lane with a sample identical to that in lane 1 was excised from the gel. In this gel slice, two wells were created for parallel separation of the 1-kb DNA ladder and another aliquot of sample 1. The DNA was then separated in the perpendicular direction in a 1.6% agarose gel and visualized with ethidium bromide. Projected migrations of the linear DNA standards are indicated with red crosses. Note migration of the full-site (FS) product along the arc defined by the linear DNA size standards, while circular DNA species (half-site [HS], o.c. and s.c. target DNA) appear above the arc. Products of multiple full-site events are expected to result in a gamut of linear DNA species of variable lengths migrating as smears in agarose gels; akin to the full-site product, these species distribute along the arc.
###end p 77
###begin p 78
(2.33 MB TIF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
We are grateful to the staff of the ESRF beamlines ID23-1 and BM14 for assistance in data collection and to Professor S. Perkins and J. Gor (University College London) for help with AUC analyses.
###end p 80
###begin title 81
References
###end title 81
###begin article-title 82
Retroviral DNA integration-mechanism and consequences.
###end article-title 82
###begin article-title 83
Retroviral DNA Integration.
###end article-title 83
###begin article-title 84
###xml 36 71 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.
###end article-title 84
###begin article-title 85
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex.
###end article-title 85
###begin article-title 86
###xml 61 96 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.
###end article-title 86
###begin article-title 87
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.
###end article-title 87
###begin article-title 88
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.
###end article-title 88
###begin article-title 89
Making and breaking nucleic acids: two-Mg2+-ion catalysis and substrate specificity.
###end article-title 89
###begin article-title 90
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Solution structure of the N-terminal zinc binding domain of HIV-1 integrase.
###end article-title 90
###begin article-title 91
###xml 60 65 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc.
###end article-title 91
###begin article-title 92
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The DNA-binding domain of HIV-1 integrase has an SH3-like fold.
###end article-title 92
###begin article-title 93
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Solution structure of the DNA binding domain of HIV-1 integrase.
###end article-title 93
###begin article-title 94
###xml 31 50 <span type="species:ncbi:11876">avian sarcoma virus</span>
Functional oligomeric state of avian sarcoma virus integrase.
###end article-title 94
###begin article-title 95
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 integrase crosslinked oligomers are active in vitro.
###end article-title 95
###begin article-title 96
Retroviral DNA integration: reaction pathway and critical intermediates.
###end article-title 96
###begin article-title 97
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.
###end article-title 97
###begin article-title 98
###xml 55 60 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.
###end article-title 98
###begin article-title 99
Menin critically links MLL proteins with LEDGF on cancer-associated target genes.
###end article-title 99
###begin article-title 100
LEDGF binds to heat shock and stress-related element to activate the expression of stress-related genes.
###end article-title 100
###begin article-title 101
Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders.
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells.
###end article-title 102
###begin article-title 103
LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro.
###end article-title 103
###begin article-title 104
The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding.
###end article-title 104
###begin article-title 105
###xml 72 78 <span type="species:ncbi:10090">murine</span>
LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes.
###end article-title 105
###begin article-title 106
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication.
###end article-title 106
###begin article-title 107
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.
###end article-title 107
###begin article-title 108
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells.
###end article-title 108
###begin article-title 109
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A role for LEDGF/p75 in targeting HIV DNA integration.
###end article-title 109
###begin article-title 110
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration.
###end article-title 110
###begin article-title 111
Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting.
###end article-title 111
###begin article-title 112
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
An essential role for LEDGF/p75 in HIV integration.
###end article-title 112
###begin article-title 113
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
###end article-title 113
###begin article-title 114
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 156 161 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase.
###end article-title 114
###begin article-title 115
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75.
###end article-title 115
###begin article-title 116
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering.
###end article-title 116
###begin article-title 117
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75.
###end article-title 117
###begin article-title 118
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.
###end article-title 118
###begin article-title 119
###xml 133 138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structure-based mutagenesis of the integrase-LEDGF/p75 interface uncouples a strict correlation between in vitro protein binding and HIV-1 fitness.
###end article-title 119
###begin article-title 120
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.
###end article-title 120
###begin article-title 121
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration.
###end article-title 121
###begin article-title 122
###xml 79 90 <span type="species:ncbi:11963">foamy virus</span>
Functional and structural characterization of the integrase from the prototype foamy virus.
###end article-title 122
###begin article-title 123
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
LEDGF/p75 interferes with the formation of synaptic nucleoprotein complexes that catalyze full-site HIV-1 DNA integration in vitro: implications for the mechanism of viral cDNA integration.
###end article-title 123
###begin article-title 124
###xml 48 83 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration.
###end article-title 124
###begin article-title 125
In vivo analysis of retroviral integrase structure and function.
###end article-title 125
###begin article-title 126
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The structural biology of HIV assembly.
###end article-title 126
###begin article-title 127
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Activity of recombinant HIV-1 integrase on mini-HIV DNA.
###end article-title 127
###begin article-title 128
The unfolding story of three-dimensional domain swapping.
###end article-title 128
###begin article-title 129
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In vitro initial attachment of HIV-1 integrase to viral ends: control of the DNA specific interaction by the oligomerization state.
###end article-title 129
###begin article-title 130
###xml 51 59 <span type="species:ncbi:9606">patients</span>
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
###end article-title 130
###begin article-title 131
###xml 40 68 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor.
###end article-title 131
###begin article-title 132
A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo.
###end article-title 132
###begin article-title 133
###xml 134 169 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication.
###end article-title 133
###begin article-title 134
###xml 133 138 <span type="species:ncbi:4932">yeast</span>
Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.
###end article-title 134
###begin article-title 135
Recent changes to the MOSFLM package for processing film and image plate data.
###end article-title 135
###begin article-title 136
Data reduction.
###end article-title 136
###begin article-title 137
The CCP 4 suite: programs for protein crystallography.
###end article-title 137
###begin article-title 138
MOLREP: an automated program for molecular replacement.
###end article-title 138
###begin article-title 139
Refinement of macromolecular structures by the maximum-likelihood method.
###end article-title 139
###begin article-title 140
PHENIX: building new software for automated crystallographic structure determination.
###end article-title 140
###begin article-title 141
Coot: model-building tools for molecular graphics.
###end article-title 141
###begin article-title 142
Phaser crystallographic software.
###end article-title 142
###begin article-title 143
###xml 20 55 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein.
###end article-title 143
###begin p 144
The authors have declared that no competing interests exist.
###end p 144
###begin p 145
NIH training grant AI07245 to MS. NIH grants AI39394 and AI70042 to AE. UK MRC grant G0600009 to PC.
###end p 145

